Cardinal Health (CAH) ended the recent trading session at $208.48, demonstrating a +1.47% change from the preceding day's ...

Fintel reports that on January 9, 2026, Citigroup upgraded their outlook for Cardinal Health (NYSE:CAH) from Neutral to Buy.

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior ...

Cardinal Health will release its second-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.

Readers hoping to buy Cardinal Health, Inc. ( NYSE:CAH ) for its dividend will need to make their move shortly, as ...

U.S. Rep. Veronica Escobar, D-El Paso, issued a letter to the CEO of Cardinal Health, Jason Hollar, after an investigation ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

In a report released today, Allen Lutz from Bank of America Securities reiterated a Buy rating on Cardinal Health, with a price target of $230.00. Claim 70% Off TipRanks Premium.

Cardinal Health is building its drug distribution portfolio with the acquisition of Kinray, Inc., a Whitestone, N.Y.-based privately held distributor of branded and generic medicines to more than ...

With the onset of the Covid-19 pandemic, Cardinal Health made the decision they needed enhanced visibility into PPE shipments as demand for these products surged. Since then, FourKites has become a ...

The COVID-19 pandemic exposed critical flaws in hospital supply chains for vital equipment like ventilators and personal protective gear. Many health systems struggled with shortages and often ...